Zobrazeno 1 - 10
of 170
pro vyhledávání: '"Menotropin"'
Autor:
Oscar Barbosa Duarte-Filho, Eduardo Hideki Miyadahira, Larissa Matsumoto, Lucas Yugo Shiguehara Yamakami, Renato Bussadori Tomioka, Sergio Podgaec
Publikováno v:
Reproductive Biology and Endocrinology, Vol 22, Iss 1, Pp 1-10 (2024)
Abstract Background The maximum daily dose of follitropin delta for ovarian stimulation in the first in vitro fertilization cycle is 12 μg (180 IU), according to the algorithm developed by the manufacturer, and based on patient’s ovarian reserve a
Externí odkaz:
https://doaj.org/article/cacc065be7744aa1b080a55f2ca84db4
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Ozge Senem Yucel Cicek, Merve Demir
Publikováno v:
Journal of Human Reproductive Sciences, Vol 15, Iss 1, Pp 51-57 (2022)
Background: Intrauterine insemination (IUI) combined with controlled ovarian stimulation (COS) results in higher pregnancy rates. However, there is still no consensus on the optimal COS protocol. Aims: In the present study, we aimed to analyse the ef
Externí odkaz:
https://doaj.org/article/666371200e3140b7b25a1a4c0fb569e6
Autor:
Jared C. Robins, M.D., Andrew F. Khair, Ph.D., M.B.A., Eric A. Widra, M.D., Michael M. Alper, M.D., Winnie W. Nelson, Pharm.D., M.S., M.B.A., Eric D. Foster, Ph.D., Anshul Sinha, B.Tech., Masakazu Ando, Ph.D., Patrick W. Heiser, Ph.D., Gaurang S. Daftary, M.D., M.B.A.
Publikováno v:
F&S Reports, Vol 1, Iss 3, Pp 257-263 (2020)
Objective: To determine the cost of achieving a live birth after first transfer using highly purified human menotropin (HP-hMG) or recombinant follicle-stimulating hormone (FSH) for controlled ovarian stimulation in predicted high-responder patients
Externí odkaz:
https://doaj.org/article/ebc490b7ea33481fa47533f0cb60e50a
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Gaurang S. Daftary, Eric Widra, Michael M. Alper, Winnie W Nelson, Jared C. Robins, Anshul Sinha, Andrew F. Khair, Eric D. Foster, Masakazu Ando, Patrick W. Heiser
Publikováno v:
F&S Reports
F&S Reports, Vol 1, Iss 3, Pp 257-263 (2020)
F&S Reports, Vol 1, Iss 3, Pp 257-263 (2020)
Objective To determine the cost of achieving a live birth after first transfer using highly purified human menotropin (HP-hMG) or recombinant follicle-stimulating hormone (FSH) for controlled ovarian stimulation in predicted high-responder patients i
Autor:
Rida Zainab, Misha Rasheed, Hafsa Younis, Muhammad Asad, Naveed Munir, Muhammad Akram, Farhat Jabeen, Ghazala Kaukab, Javaria Nawaz, Muhammad Wajahat Ameer, Amnah Bashir
Publikováno v:
Fish Physiology and Biochemistry. 47:1559-1564
The applications of exogenous hormones in different species for the induction of oocyte production, final oocyte maturation (FOM), and spawning for their reproduction is getting more attention day by day. The current preliminary research work was car
Autor:
Camilla Teles Vidal de Paula, Thiago Lopes Dos Santos, Anderson Sanches de Melo, Jorge Barreto, Rebecca Pontelo Barboza, Victor Antonio Costa Faria, Marcelo Augusto Feres Rufato
Publikováno v:
JBRA assisted reproduction. 26(2)
Objective To compare the number of oocytes obtained in the follicular puncture of high- responder oocyte donors, submitted to ovarian stimulation for in vitro fertilization (IVF) in two different protocols: Friendly and Conventional. Methods There we
Autor:
Johan Smitz, Claire Bourgain, Herman Tournaye, Panagiotis Drakopoulos, Inge Van Vaerenbergh, Michel De Vos, Carolina Ortega-Hrepich, Luis Guzman
Publikováno v:
Reproductive Biology. 19:210-217
Clinical outcomes of fresh embryo transfer in non-hCG triggered in vitro maturation (IVM) cycles are inferior compared to vitrified-warmed embryo transfer. This is a prospective observational pilot study in a consecutive cohort of 31 polycystic ovary
Publikováno v:
Steinke, D, Zarroung, O H, Mathur, R, Kendrew, H & Jenkins, J 2020, ' Qualitative risk assessment of follicle stimulating hormone injectable products ', Expert Opinion on Drug Delivery . https://doi.org/10.1080/17425247.2020.1813106
Background: Gonadotropin injections for fertility treatment regimens are usually self-injected, typically over 8 to 12 days during the assisted reproductive technology cycle. Parenteral gonadotropins are available in different formulations and admini
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::32d9cb76b6de8e943a5e6a9c620c4b73
https://doi.org/10.1080/17425247.2020.1813106
https://doi.org/10.1080/17425247.2020.1813106